Back

Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study

2020-05-25 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundHydroxychloroquine has been touted as a COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has been proposed as a treatment of critically ill patients. ObjectiveTo describe the association between mortality and hydroxychloroquine or tocilizumab therapy among hospitalized COVID-19 patients. DesignRetrospective observational cohort study of electronic health records Setting: 13-hospital network spanning the state of New Jersey. ParticipantsPatients hospitalized between March 1, 20...

Predicted journal destinations

1
Clinical Infectious Diseases
219 training papers
Top 0.8% 14.1%
2
Clinical Microbiology and Infection
54 training papers
#1 11.4%
3
PLOS ONE
1737 training papers
Top 63% 8.7%
4
Open Forum Infectious Diseases
124 training papers
Top 0.5% 6.2%
5
JAMA Network Open
125 training papers
Top 4% 4.0%
6
The Journal of Infectious Diseases
137 training papers
Top 3% 3.7%
7
Scientific Reports
701 training papers
Top 68% 3.7%
8
New England Journal of Medicine
49 training papers
Top 0.9% 2.7%
9
BMC Infectious Diseases
110 training papers
Top 4% 2.7%
10
Nature Communications
483 training papers
Top 38% 1.9%
11
International Journal of Infectious Diseases
115 training papers
Top 8% 1.9%
12
Journal of Medical Virology
95 training papers
Top 5% 1.9%
13
BMJ Open
553 training papers
Top 55% 1.5%
14
BMJ
49 training papers
Top 2% 1.5%
15
Journal of Infection
64 training papers
Top 5% 1.3%
16
Frontiers in Medicine
99 training papers
Top 14% 1.3%
17
Infectious Diseases and Therapy
18 training papers
Top 0.3% 1.1%
18
Journal of Antimicrobial Chemotherapy
19 training papers
Top 0.5% 1.1%
19
BMC Medicine
155 training papers
Top 24% 1.1%
20
The Lancet Infectious Diseases
57 training papers
Top 6% 0.9%
21
Journal of Clinical Microbiology
77 training papers
Top 6% 0.9%
22
Nature Medicine
88 training papers
Top 13% 0.9%
23
Emerging Infectious Diseases
84 training papers
Top 14% 0.9%
24
PLOS Medicine
95 training papers
Top 18% 0.9%
25
Vaccine
140 training papers
Top 11% 0.7%
26
Journal of Clinical Virology
54 training papers
Top 8% 0.7%
27
Frontiers in Immunology
140 training papers
Top 14% 0.7%
28
The Lancet
16 training papers
Top 0.4% 0.7%
29
eClinicalMedicine
55 training papers
Top 6% 0.7%
30
Annals of Internal Medicine
27 training papers
Top 1% 0.7%